Fairmount Funds Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $99M | Hold |
|
|||||
|
2025
Q2 | $85.1M | Hold |
|
|||||
|
2025
Q1 | $95.1M | Sell |
|
|||||
|
2024
Q4 | $124M | Sell |
|
|||||
|
2024
Q3 | $212M | Hold |
|
|||||
|
2024
Q2 | $190M | Hold |
|
|||||
|
2024
Q1 | $188M | Hold |
|
|||||
|
2023
Q4 | $188M | Buy |
|
|||||
|
2023
Q3 | $164M | Sell |
|
|||||
|
2023
Q2 | $169M | Buy |
|
|||||
|
2023
Q1 | $124M | Hold |
|
|||||
|
2022
Q4 | $155M | Buy |
|
|||||
|
2022
Q3 | $84.6M | Buy |
|
|||||
|
2022
Q2 | $36.1M | Hold |
|
|||||
|
2022
Q1 | $39M | Buy |
|
|||||
|
2021
Q4 | $7.09M | Hold |
|
|||||
|
2021
Q3 | $6.18M | Sell |
|
|||||
|
2021
Q2 | $21.1M | Buy |
|
|||||
|
2021
Q1 | $14.2M | Buy |
|
|||||
|
2020
Q4 | $17.9M | Hold |
|
|||||
|
2020
Q3 | $15.7M | Buy |
|
|||||
|
2020
Q2 | $17.8M | Buy |
|
|||||
|
2020
Q1 | $11.2M | Buy |
|